AIHTA - Publications - Search - Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors

Adlbrecht, C. and Wild, C. (2010): Radionuclide therapy - 90Yttrium and 177Lutetium somatostatin analogues for the treatment of inoperable neuroendocrine tumors. Decision Support Document 40.

[thumbnail of DSD_40.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
300kB
Abstract

Item Type:Decision Support Document
Keywords:Radionuclide therapy, 90Yttrium, Y-90, 177Lutetium, LU-177, somatostatin analogues, neuroendocrine tumors, NET, gastrointestinal tract, palliative care
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
WK Endocrine system > WK 800-920 Islets of Langerhans and gonads
WB Practice of medicine > WB 310 Palliative care
WK Endocrine system > WK 500-590 Pituitary gland
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WI Digestive system > WI 400-560 Intestines
Language:German
Series Name:Decision Support Document 40
Deposited on:14 Jul 2010 17:25
Last Modified:15 Jul 2020 17:44

Repository Staff Only: item control page